Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

How Greater Collaboration and Access to Data can Help Tackle Rare Diseases

Posted on November 1st, 2018 by in Pharma R&D

It is estimated that 30 million people in the United States alone are living with one of 7,000 rare diseases, this equates to 10% of the population. There is, however, little financial incentive for the pharmaceutical sector to develop new treatments for these diseases because of the small patient population each disease affects. Continue reading “How Greater Collaboration and Access to Data can Help Tackle Rare Diseases” »

A gathering of global perspectives… a look at DIA’s annual meeting: Post 2 of 2

Posted on July 18th, 2016 by in Pharma R&D

As referenced in my last post, the Drug Information Association (DIA), held its annual conference in Philadelphia at the end of June with this year’s theme being “A Gathering of Global Perspectives.” In follow-up to that post, I want to share with you what I gleaned from two additional noteworthy sessions. Continue reading “A gathering of global perspectives… a look at DIA’s annual meeting: Post 2 of 2” »

Using Text Mining to Find Treatments for Rare Diseases

Posted on May 5th, 2016 by in Pharma R&D

When you compare PubMed search results for rare diseases, such as “congenital hyperinsulinism” (767), schwannomatosis (250) or “Mabry syndrome” (34), to that of “diabetes” (542,987), “heart attack” (217,694) or “obesity” (237,307), the disparity in attention becomes much more obvious. Continue reading “Using Text Mining to Find Treatments for Rare Diseases” »